Genflow Biosciences (GENF)

Sector:

Pharma and Biotech

1.20p
   
  • Change Today:
      0.050p
  • 52 Week High: 3.30
  • 52 Week Low: 1.10
  • Currency: UK Pounds
  • Shares Issued: 349.71m
  • Volume: 48,486
  • Market Cap: £4.20m
  • Beta: 0.00

GENF Overview

Genflow Biosciences plc is a UK based biotech company with R&D facilities in Belgium and a US office in Cambridge, MA, driven by one mission: to deliver therapeutics that potentially halt or slow the ageing process in humans and dogs.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn n/a n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue n/a n/a
Pr/Book 5.5  
Latest F'cast
Revenue n/a n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

GENF Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-21 n/a (0.99) (0.59)p n/a n/a n/a n/a 0.0%
31-Dec-22 n/a (1.34) (0.46)p n/a n/a n/a n/a 0.0%
31-Dec-23 n/a (1.63) (0.56)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

GENF Company Announcements

Holding in Company 28-Mar-2025 07:10 RNS
Director Dealings 28-Mar-2025 07:00 RNS
Institutional Investment 26-Mar-2025 07:00 RNS

GENF ShareCast News

No recent information was found.

Latest GENF Director Deals

Traded Action Notifier PriceAmountValue
27-Mar-25 Placing Eric Leire 1.15p 2,100,000 £24,150.00

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

GENF Market Data

Currency UK Pounds
Share Price 1.20p
Change Today 0.050p
% Change 4.35 %
52 Week High 3.30
52 Week Low 1.10
Volume 48,486
Shares Issued 349.71m
Market Cap £4.20m
Beta 0.00

GENF Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
51.95% below the market average51.95% below the market average51.95% below the market average51.95% below the market average51.95% below the market average
57.45% below the sector average57.45% below the sector average57.45% below the sector average57.45% below the sector average57.45% below the sector average
Price Trend
60.72% below the market average60.72% below the market average60.72% below the market average60.72% below the market average60.72% below the market average
26.53% below the sector average26.53% below the sector average26.53% below the sector average26.53% below the sector average26.53% below the sector average
Income Not Available
Growth Not Available

GENF Dividends

No dividends found

Trades for 31-Mar-2025

Time Volume / Share Price
13:30 16,723 @ 1.19p
13:07 13,340 @ 1.10p
13:06 16,095 @ 1.19p
10:43 40 @ 1.20p
09:30 124 @ 1.20p

GENF Key Personnel

CEO Eric Leire

Top of Page